Details for Patent: 4,746,680

Summary for Patent: 4,746,680

Title:	Therapeutic agents
Abstract:	Compounds of formula I ##STR1## in which R.sub.1 is C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-7 cycloalkyl, cycloalkylalkyl or optionally substituted phenyl; R.sub.2 is H or C.sub.1-3 alkyl; R.sub.3 and/or R.sub.4 are H, formyl, C.sub.1-3 alkyl, C.sub.3-6 alkenyl, C.sub.3-6 alkynyl, C.sub.3-7 cycloalkyl or R.sub.3 and R.sub.4 together with the nitrogen atom form a heterocyclic ring system; R.sub.5 and/or R.sub.6 are H, halo, CF.sub.3, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, C.sub.1-3 alkylthio or R.sub.5 and R.sub.6 together with the carbon atoms to which they are attached form a second benzene ring show therapeutic activity in the treatment of depression. Pharmaceutical compositions and processes for preparing compounds of formula I are disclosed.
Inventor(s):	Jeffery; James E. (Nottingham, GB), Kozlik; Antonin (Nottingham, GB), Wilmshurst; Eric C. (Nottingham, GB)
Assignee:	The Boots Company p.l.c. (GB2)
Application Number:	06/725,206
Patent Claim Types: see list of patent claims	Compound; Use; Composition;

Drugs Protected by US Patent 4,746,680

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,746,680

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	8110709	Apr 06, 1981

International Family Members for US Patent 4,746,680

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	382612
Austria	A132582
Australia	545595
Australia	8221382
Belgium	892758
Bulgaria	40651
Bulgaria	40652